Top compounds associated with response to HOXC9


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.8
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.014 0.8
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.0084 0.8
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.013 0.8
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.0092 0.8
Download CSV